Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

To standardize comprehensive biomarker testing in patients with NSCLC, Oncology Hematology Care, Inc., developed and implemented a 1-year quality improvement (QI) project that included custom data reports and monitoring dashboards to ensure practice-wide adoption and sustainability across multiple clinic sites.
PowerPoint Presentation Key TakeawaysContext: MACRA Repealed the SGR Formula No “doc fix” in 2015 would have meant a 21% cut in payments to physicians. Medicare Access and CHIP Reauthorization Act (MACRA) repealed the SGR formula and replaced it with the Quality Payment Program (QPP) • MACRA changed the way in which physicians are reimbursed under Medicare for physician services …
August 16, 2023
Join us for the 3rd HSCO 2023 Symposium featuring Kent Mouw, MD, Ph.D, a Radiation Oncology Physician-Scientist and Co-Director of the Bladder Cancer Center at Dana-Farber Cancer Institute. This complimentary symposium presents an opportunity to dine, network with professionals from across the state, and participate in stimulating conversations about the most recent discoveries in bladder cancer. …
August 15, 2023
Learn about the key proposals in the CY 2024 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) and their potential impact on your program or practice during the “Highlights From the 2024 MPFS and HOPPS Proposed Rules” webinar.
The rapid evolution of cancer care delivery toward multi-agent regimens, oral and/or combination therapies, and at-home treatment administration has made cancer caregiving extremely complex. The Caregiver Clinic at Memorial Sloan Kettering provides support to people who are having difficulty coping with the demands of being a caregiver. The purpose of this clinic is to help individuals maximize their …
For patients with pancreatic cancer, clinical trials should be considered as a possible treatment option early on, not a last resort when all else fails. The Let's Win team discusses why.
Texas Society of Medical Oncology Educational Award for Allied Health Professionals Submission Deadline: Friday, September 8, 2023 OVERVIEW The Nevada Oncology Society (NOS) is committed to focusing on the future of cancer care In Nevada by sup- porting the professional development of Advanced Practice Providers, Pharmacists and Registered Nurses in the state. The leadership …
Texas Society of Medical Oncology Educational Award for Allied Health Professionals Submission Deadline: Friday, September 29, 2023 OVERVIEW The Rocky Mountain Oncology Society (RMOS) is committed to focusing on the future of cancer care in Colorado by supporting the professional development by supporting the professional development of Advanced Practice Providers, Pharmacists …
Wyoming State Oncology Society August 22, 2023 *As of 8/21/2023 Attendee Roster First Name Last Name Title Organization Molly Skifstad, PharmD Pharmacist Essentia Health Cancer Center-Duluth Lisa Anderson Exelixis Steve Pinckney Oncology Account Specialist Exelixis Jordan Karlitz Senior Medical Director, Medical Affairs GRAIL Inc Tiffany Ziliani Key Accounts Associate Director …
Texas Society of Medical Oncology Educational Award for Allied Health Professionals Submission Deadline: Friday September 29, 2023 OVERVIEW The Minnesota Society of Clinical Oncology (MSCO) is committed to focusing on the future of cancer care in Minnesota by supporting the professional development of Advanced Practice Providers, Phar- macists and Registered Nurses in …
ACCC recognizes September as Ovarian Cancer Awareness Month in an upcoming webinar series.
TxSCO ONCOLOGY DRUG NEWSLETTER A U G U S T 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Glofitamab-gxbm (Columvi) The FDA granted accelerated approval to glofitamab- gxbm (Columvi) for adult patients with relapsed/ refractory diffuse large B-cell lymphoma …
NCOA ONCOLOGY DRUG NEWSLETTER FDA APPROVALS Glofitamab-gxbm (Columvi) The FDA granted accelerated approval to glofitamab- gxbm (Columvi) for adult patients with relapsed/ refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified or large B-cell lymphoma arising from follicular lymphoma, after at least 2 lines of systemic therapy. In the phase 1/2 NP30179 trial …
SCOS ONCOLOGY DRUG NEWSLETTER A U G U S T 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Glofitamab-gxbm (Columvi) The FDA granted accelerated approval to glofitamab- gxbm (Columvi) for adult patients with relapsed/ refractory diffuse large B-cell lymphoma …
TACOS ONCOLOGY DRUG NEWSLETTER A U G U S T 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Glofitamab-gxbm (Columvi) The FDA granted accelerated approval to glofitamab- gxbm (Columvi) for adult patients with relapsed/ refractory diffuse large B-cell lymphoma …
Indiana Oncology Society Practice Summit August 11th, 2023 Sheraton Indianapolis Hotel at Keystone Crossing Indianapolis, IN Attendee Roster First Name Last Name Title Account Name Stephanie McCann Account Executive AbbVie Dava Sprigler CPC American Health Network Gina Borden Practice Administrator American Health Network Greg Waties Oncology Portfolio Manager Amgen Oncology …
August 11, 2023
The Indiana Oncology Society (IOS) 2023 Oncology Practice Summit will offer engaging sessions that explore strategies to improve cancer practice operations and enhance cancer care delivery. Join us on Friday, August 11 to hear from renowned speakers who will discuss practical solutions and key strategies to help create the positive change your clinicians, staff, and patients deserve. *Any admin, …
Immersed in The Treatment Team: Addressing and Healing Financial Toxicity with Comprehensive Financial Navigation Practices. Indiana Oncology Society Oncology Practice Summit August 11, 2023 Aimee Hoch, LSW, OSW-C Oncology Financial Navigator Grand View Health ahoch@gvh.org The Beginning of Financial Navigation at GVH 2 “ I can either pay for my treatment …
INDIANA UNIVERSITY MELVIN AND BREN SIMON COMPREHENSIVE CANCER CENTER INDIANA UNIVERSITY MELVIN AND BREN SIMON COMPREHENSIVE CANCER CENTER End Lung Cancer Now: Advocacy for Awareness, Research, and Prevention MacKenzie Church Executive Director, End Lung Cancer Now Thoracic Program Manager, IU Simon Comprehensive Cancer Center INDIANA UNIVERSITY MELVIN AND BREN SIMON …